000 -LEADER |
fixed length control field |
00923nam a22002297a 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20160601104729.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
160601b xxu||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0917330102 |
040 ## - CATALOGING SOURCE |
Transcribing agency |
UG |
050 ## - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM302 |
Item number |
A4 1976 |
110 ## - MAIN ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
American Pharmaceutical Association |
245 ## - TITLE STATEMENT |
Title |
Evaluation of drug interaction.- |
250 ## - EDITION STATEMENT |
Edition statement |
2 nd |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Washington, D.C.: |
Name of publisher, distributor, etc |
A.P.A., |
Date of publication, distribution, etc |
1976. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
XLiii, 520p. |
Other physical details |
ill,diagrs,graphs |
500 ## - GENERAL NOTE |
General note |
Prepared by the American Pharmaceutical Association with cooperation and assistance by The American Dental Association, The American Podiatry Association,The American Society of Hospital Pharmacists, The Food and Drug Administration,The National Library Medicine. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references. |
610 ## - SUBJECT ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
American Pharmaceutical Association |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug interactions |
9 (RLIN) |
75029 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Entry Department |
HSRC |
Source of classification or shelving scheme |
|
Verified |
O.H |